Role of triptorelin and single fixed-time artificial insemination on productive and reproductive performance of hyperprolific sows
Veterinary and Animal Science · 2025-12 · 30 · 100505
DOI: 10.1016/j.vas.2025.100505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Animal Science, 2025-12. Verfasst von María Victoria Falceto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Pathology, Agroalimentary Institute of Aragon-IA2, Universidad de Zaragoza-CITA, 50.013 Zaragoza, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Single fixed-time artificial insemination (SFTAI) provides a streamlined approach to improving reproductive management. We evaluated the impact of incorporating triptorelin acetate (GnRH agonist) into a SFTAI protocol on a commercial farm. Hyperprolific sows not in estrus by day 4 post-weaning were randomly assigned to two groups. Group-1 (G1; n = 243) received no triptorelin treatment and daily post-cervical artificial inseminations (PCAI) based on estrus detection (2.59±0.034 inseminations/sow). Group-2 (G2; n = 249) received a single intravaginal dose of triptorelin (0.2 mg) at 96 ± 2 h post-weaning, then one PCAI 22 ± 2 h later. No significant differences (P > 0.05) between groups in conception rate (G1: 98.8 %; G2: 97.6 %), farrowing rate (G1:95.1 %; G2: 94.4 %) or litter characteristics (total born, live-, stillborn and mummified piglets). Both groups showed similar delivery batch durations (P = 0.414). Distribution of deliveries during the delivery period was similar (P = 0.455). Induction of labor was need more frequently in G1 (P < 0.001). G2 had a higher proportion of sows with shorter gestations (112-115 days: 166/235, 70.6 %) compared to G1 (112-115 days: 82/231; 35.5 %, P < 0.001). A significantly higher proportion of G2 piglets received longer lactation (27 - 33 days) compared to G1 (2210/3023=73.1 % vs 2774/4395=63.1 %; P = 0.032). G1 had a higher proportion of low-weight piglets (≤4.0 kg; 716/43950= 16.3 % vs.435/3023= 14.4 %; while G2 had more heavy piglets (≥6.5 kg; 1228/3023=40.5 % vs.1675/4395= 38.1 %) (P = 0.027). Observed differences in lactation length could be responsible for these weaning weight differences, rather than triptorelin treatment itself. This protocol did not worsen productive and reproductive performances.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Animal Pathology, Agroalimentary Institute of Aragon-IA2, Universidad de Zaragoza-CITA, 50.013 Zaragoza, Spain.
- Vetoquinol Especialidades Veterinarias S.A., 28108, Madrid, Spain.
- Department of Anatomy, Embryology and Animal Genetics, CiberCV, Universidad de Zaragoza, 50.013 Zaragoza, Spain.
- Vetoquinol N.-A. Inc., J5T3S5, Lavaltrie, Canada.
- Mazana Grupo empresarial, 22480 Capella, Huesca, Spain.
Zitieren
APA
Falceto, M. V., Reyero, D., Tejedor, M. T., Renaud, P., Mateu, A., Lafuente, A., Bonastre, C., Laborda, A., Garrido, A. M., & Mitjana, O. (2025). Role of triptorelin and single fixed-time artificial insemination on productive and reproductive performance of hyperprolific sows. Veterinary and Animal Science, 30, 100505. https://doi.org/10.1016/j.vas.2025.100505
Vancouver
Falceto MV, Reyero D, Tejedor MT, Renaud P, Mateu A, Lafuente A, et al. Role of triptorelin and single fixed-time artificial insemination on productive and reproductive performance of hyperprolific sows. Veterinary and Animal Science. 2025;30:100505. doi:10.1016/j.vas.2025.100505
BibTeX
@article{Falceto2025,
author = {Falceto, María Victoria and Reyero, David and Tejedor, María Teresa and Renaud, Paul and Mateu, Ana and Lafuente, Antonio and Bonastre, Cristina and Laborda, Alicia and Garrido, Ana Maria and Mitjana, Olga},
title = {Role of triptorelin and single fixed-time artificial insemination on productive and reproductive performance of hyperprolific sows},
journal = {Veterinary and Animal Science},
year = {2025},
volume = {30},
pages = {100505},
doi = {10.1016/j.vas.2025.100505}
}
EUVIMED